Opinion Poll 意見調查 Email Alert 電郵快訊


Story maps

COVID-19 vaccination coverage in Asia 亞洲新冠疫苗接種覆蓋率

(added on 2021/03/05)

© 2021 SpatioEpi.com
Data source: World Health Organization, Our World in Data, and media reports
Map created by CUHK SpatioEpi Group


Situation update as of 22 February 2021

After the SARS-coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV), a new coronavirus virus (SARS-CoV-2) emerged in China in December 2019. Coronavirus Disease (COVID-19) is the name given to the medical condition caused by SARS-CoV-2. As of 22nd February 2021, more than 110,000,000 confirmed cases were reported affecting over 200 countries and places. According to the World Health Organization’s (WHO) assessment, the risk of acquiring the SARS-CoV-2 infection at the global level is very high.

The map shows in graduated colors the distribution of the total number of cumulative confirmed COVID-19 cases in Asia. Overall, India, Indonesia, Iran, Iraq, Israel, Pakistan, and Turkey have recorded a higher number of cases compared to other countries in Asia.

Currently, there are at least 70 COVID-19 vaccine candidates in trials. More than twenty countries in Asia have approved the COVID-19 vaccines for emergency use. Eight COVID-19 vaccines from different developers are used in Asia. The pie's color shows the available vaccines in each country, while the size of each pie shows the cumulative number of vaccination doses administered per 100 people, as of 22 February 2021. From the sizes of the pies, it can be seen that Israel and the United Arab Emirates have reported the highest proportion of vaccination coverage. Also, the United Arab Emirates has the highest number of options for COVID-19 vaccines. Vaccination aside, precautions for protecting from SARS-CoV-2 should continue: comply with social distancing regulation; wash hands frequently; avoid close and prolonged contacts with crowds in the community; wear a mask in accordance with the advice of the local health authority.

Data for the map were obtained from the World Health Organization, Our World in Data, and media reports.


繼沙士冠狀病毒及中東呼吸綜合症冠狀病毒,一種新型冠狀病毒 (SARS-CoV-2) 於2019年12月於中國出現。2019冠狀病毒病 (COVID-19),俗稱『新冠肺炎』,是由 SARS-CoV-2 所導致。截至2021年2月22日,全球已有多於 110,000,000例確診病例和200多個國家及地區受影響。根據世界衛生組織(WHO)的風險評估,在全球層面的感染風險非常高。

地圖使用漸變色顯示了在亞洲累計確診新冠肺炎病例的分佈。總體而言, 印度、印度尼西亞、伊朗 、伊拉克、以色列、巴基斯坦和土耳其的累計確診病例數目比其他亞洲國家高。

現時最少有70種COVID-19疫苗已經進行試驗中。在亞洲有超過20個國家已經緊急批准使用疫苗。在亞洲,由不同開發商生產的疫苗有8款正在使用中。餅型圖利用了顏色去顯示每個國家可供注射的疫苗,而餅型圖的大小則表示了截止2021年2月22日每個國家累計每100人已接種疫苗的數目。從餅型圖的大小可以看出以色列和阿拉伯聯合酋長國有最高的疫苗接種率。同樣,阿拉伯聯合酋長國提供最多COVID-19 疫苗的選擇。除了接種疫苗外,應該繼續採取預防SARS-CoV-2的措施:遵守社交距離防疫措施、勤洗手、避免近距離和長時間接觸人群和根據各地衛生部門建議佩戴口罩。

地圖資料源自世界衛生組織, Our World in Data及不同的媒體報導。

Related maps 相關地圖

Other resources 其他資訊

Further information 詳細資料